HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chien-Wei Su Selected Research

Fetal Proteins (Fetoprotein)

7/2022Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
1/2022A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma.
11/2021Easy albumin-bilirubin score as a new prognostic predictor in hepatocellular carcinoma.
1/2021Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
4/2020Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade.
1/2019Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
1/2019An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.
11/2017Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.
12/2014A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.
9/2014Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chien-Wei Su Research Topics

Disease

56Hepatocellular Carcinoma (Hepatoma)
11/2022 - 01/2008
48Neoplasms (Cancer)
11/2022 - 11/2009
22Chronic Hepatitis B
04/2022 - 11/2008
20Fibrosis (Cirrhosis)
01/2022 - 10/2009
14Liver Neoplasms (Liver Cancer)
11/2021 - 06/2010
12Infections
04/2022 - 05/2007
12Ascites
01/2022 - 01/2010
9Neoplasm Metastasis (Metastasis)
01/2022 - 06/2010
9Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 03/2011
8Hepatitis B
07/2022 - 01/2008
8Chronic Hepatitis C
01/2022 - 01/2017
5Disease Progression
02/2022 - 03/2011
5End Stage Liver Disease
02/2018 - 07/2008
5Hemorrhage
12/2012 - 10/2009
4Hepatitis
04/2021 - 11/2002
4Liver Diseases (Liver Disease)
01/2021 - 11/2002
4Esophageal and Gastric Varices (Esophageal Varices)
01/2018 - 06/2010
4Fatty Liver
01/2017 - 01/2013
3Inflammation (Inflammations)
01/2021 - 10/2011
3Acute Kidney Injury (Acute Renal Failure)
12/2018 - 01/2010
3Chronic Hepatitis D
04/2009 - 05/2007
2Sepsis (Septicemia)
01/2022 - 01/2020
2Thrombocytopenia (Thrombopenia)
08/2021 - 10/2020
2Hepatitis C
01/2021 - 03/2016
2Renal Insufficiency (Renal Failure)
04/2020 - 09/2010
2Liver Failure
02/2020 - 01/2020
2Hepatic Encephalopathy
01/2020 - 01/2014
2Fatigue
03/2019 - 02/2019
2Pruritus (Itching)
03/2019 - 01/2008
2Diabetes Mellitus
01/2018 - 10/2015
2Splenomegaly
06/2017 - 10/2012
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2017 - 03/2015
2Carcinogenesis
12/2016 - 05/2009
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
10/2009 - 01/2008
1Neutropenia
02/2022
1Rupture
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Exanthema (Rash)
12/2020
1Varicose Veins (Varicose Vein)
10/2020
1Thrombocytosis (Thrombocythemia)
10/2020
1Hepatitis D
05/2020

Drug/Important Bio-Agent (IBA)

25AlbuminsIBA
07/2022 - 12/2011
24BilirubinIBA
07/2022 - 01/2014
15Fetal Proteins (Fetoprotein)IBA
07/2022 - 05/2011
15Antiviral Agents (Antivirals)IBA
01/2022 - 09/2010
15Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 01/2008
13InterferonsIBA
01/2022 - 01/2011
12alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2020 - 01/2010
10Alanine Transaminase (SGPT)IBA
01/2021 - 10/2009
9Hepatitis B e AntigensIBA
09/2021 - 06/2010
7Ribavirin (Virazole)FDA LinkGeneric
03/2021 - 01/2015
7CreatinineIBA
02/2021 - 10/2012
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2008
7Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2020 - 10/2009
7Serum AlbuminIBA
12/2018 - 01/2012
6Sorafenib (BAY 43-9006)FDA Link
11/2022 - 03/2015
6Biomarkers (Surrogate Marker)IBA
11/2021 - 09/2010
5Cytidine Triphosphate (CTP)IBA
11/2021 - 07/2010
5SodiumIBA
11/2017 - 01/2010
4RNA (Ribonucleic Acid)IBA
09/2019 - 03/2008
3peginterferon alfa-2a (Pegasys)FDA Link
09/2021 - 01/2013
3EnzymesIBA
01/2021 - 10/2015
2SofosbuvirIBA
01/2022 - 09/2019
2Hepatitis delta Antigens (HDAg)IBA
05/2020 - 05/2007
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020 - 12/2016
2Propranolol (Inderal)FDA LinkGeneric
01/2020 - 03/2015
2daclatasvirIBA
09/2019 - 02/2019
2entecavirFDA Link
12/2018 - 11/2008
2AntigensIBA
12/2016 - 06/2010
2Alkaline PhosphataseIBA
03/2016 - 01/2016
2CholesterolIBA
03/2015 - 01/2013
2Triglycerides (Triacylglycerol)IBA
03/2015 - 01/2015
2Glucose (Dextrose)FDA LinkGeneric
03/2015 - 01/2013
2Lamivudine (Epivir)FDA Link
12/2013 - 11/2008
2Contrast MediaIBA
09/2010 - 01/2010
2EpitopesIBA
04/2009 - 05/2007
1Phosphotransferases (Kinase)IBA
11/2022
1Valproic Acid (Depakote)FDA LinkGeneric
02/2022
1Cisplatin (Platino)FDA LinkGeneric
02/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022
1Dacarbazine (DIC)FDA LinkGeneric
02/2022
1GemcitabineFDA Link
02/2022
1Hydralazine (Apresoline)FDA LinkGeneric
02/2022
1NivolumabIBA
01/2022
1regorafenibIBA
01/2022
1CalciumIBA
01/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1Transaminases (Aminotransferases)IBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2020
1Transforming Growth Factor beta (TGF-beta)IBA
05/2020

Therapy/Procedure

40Therapeutics
02/2022 - 11/2002
15Radiofrequency Ablation
10/2020 - 01/2008
8Surgical Instruments (Clip)
04/2021 - 06/2010
4Liver Transplantation
01/2019 - 07/2008
3Drug Therapy (Chemotherapy)
02/2022 - 12/2018
2Contraindications
01/2022 - 01/2017
2Retreatment
02/2020 - 11/2015
2Blood Transfusion (Blood Transfusions)
11/2017 - 11/2002
1Tertiary Prevention
04/2021
1Injections
12/2020